BOULDER, Colo.--Bioinformatics company Genomica here has announced that Arnold Levine, a codiscoverer of the p53 tumor suppressor gene, has joined the company's board of directors. In addition, the company made two other key staff appointments. Levine is professor of the department of molecular biology at Princeton. Thomas Marr, Genomica's president and CEO, observed, "his scientific expertise is a tremendous asset and will help direct the company as we expand our product base."
Meanwhile, Genomica also announced two new hires. Susan Strong has joined the company as senior director of marketing and sales, and Kenneth Forman is Genomica's new senior director of customer services. "We are continuing to build a solid management infrastructure," Marr commented. Genomica's key product is its Discovery Manager software, which offers a range of tools for clinical and genetic analysis, physical mapping, sequence analysis, and functional analysis. Marr founded the company in 1996 to commercialize tools he and his team developed at the Cold Spring Harbor Laboratory.